Skip to main content
OpenTrials
Completed

NCT Number: NCT04089917

A Study of the Use of the Q Aspiration Catheter to Remove Clot in Stroke Patients

The purpose of this study is to collect real-world safety and performance data on the MIVI Neuroscience, Inc. Q Aspiration Catheter for use in the removal of fresh, soft emboli and thrombi in the neurovascular system during acute ischemic stroke.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Hospital Universitario 12 De Octubre, Madrid, Spain

Loading trial locations.

About this study

The purpose of this study is to demonstrate the safety and performance of the MIVI Neuroscience, Inc. CE Marked Q Aspiration Catheter for use in the removal of fresh, soft emboli and thrombi in the neurovascular system during acute ischemic stroke. The study is an observational study collecting Q Aspiration Catheter use that will enroll a maximum of 50 subjects at a maximum of 5 sites in Spain. Subjects data will be collected through hospitalization with a 3 months post-procedure study visit. This study is designed for observational data to be collected and reported.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 18 to 85 years;
  • Diagnosis of acute ischemic stroke with mechanical thrombectomy procedure < 8 hours from onset of symptoms/ last known well;
  • Large Vessel Occlusion on CT or MRI in the anterior cerebral vasculature up to A1, M1, or M2 or the posterior cerebral vasculature;
  • ASPECTS 6 - 10 or volume of diffusion restriction < 50 mL;
  • Use of the Q Aspiration Catheter as the first line treatment according to the IFU;
  • Signed informed consent by patient or legally authorized representative.

Exclusion criteria

  • Occlusions in multiple vascular territories, extracranial occlusion or tandem occlusion;
  • Evidence of dissection in the carotid or target artery for treatment;
  • Evidence of recent/fresh haemorrhage on presentation;
  • Unwilling to agree to a 3-month follow up visit.

Treatment and study plan

Q Aspiration Catheter

Device

The Q Aspiration Catheter is indicated for use in the removal of fresh, soft emboli and thrombi in the neurovascular system.

Primary outcomes

  1. Successful Revascularization Rate

    Time frame: intra-procedural

    Defined as final modified Thrombolysis In Cerebral Infarction scale (mTICI 2b-3) flow in the target vessel

  2. Symptomatic Intracranial Haemorrhage Rate

    Time frame: 24 hours post procedure

    Defined as the symptomatic intracranial haemorrhage as detected by CT/MRI with an NIHSS change of >/= 4 points

Secondary outcomes

  1. Successful Revascularization Rate Using the Q Aspiration Catheter as the Only Thrombectomy Device

    Time frame: intra-procedural

    Defined as mTICI 2b-3 flow in the target vessel post-treatment with the Q Catheter (first line therapy)

  2. Rate of Embolization to a New Neurovascular Territory (ENT)

    Time frame: intra-procedural

    As measured by independent Angiographic Core Lab

  3. Good Functional Outcome Measured by Modified Rankin Scale Score of 0-2

    Time frame: 90 days

    The Modified Rankin Scale (mRS) measures neurological disability or dependence for stroke patients on a scale of 0 (no symptoms) to 6 (deceased).

  4. Mortality Rate

    Time frame: 90 days

    Rate of all cause mortality

Sponsors and collaborators

Lead sponsor

MIVI Neuroscience, Inc.

Industry

Registry information

Official study title

An Observational Study of the Q Aspiration Catheter Used During Neurointervention for Acute Large Vessel Ischemic Stroke in Spain.

Acronym: TAPAS

Important dates

Study start
2019
Primary completion
2021
Study completion
2021
First posted
Sep 13, 2019
Registry last updated
Sep 7, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.